Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Ascentage Pharma Group Inc.
Scientific Title
A Phase Ib/II Study of APG-115 in Combination With Pembrolizumab in Patients With Unresectable or Metastatic Melanomas or Advanced Solid Tumors